Stem-cell Start-ups Seek to Crack the Mass-Production Problem - Kytopen

Stem-cell Start-ups Seek to Crack the Mass-Production Problem - Kytopen

In the laboratory, induced pluripotent stem (iPS) cells can seem like magic: derived from differentiated cells, they can then morph into surprisingly good replacements for pancreatic, brain, eye, heart and other cells.

To wake up cancer stem cells, or to let them sleep, that is the

Kytopen Reveals Automated High-Throughput Gene Editing Platform to

Stem-cell Start-ups Seek to Crack the Mass-Production Problem

Frontiers Uncovering Pharmacological Opportunities for Cancer

Study reveals explosion of unproven stem-cell treatment in U.S.

Addressing the Manufacturing Challenges of Cell-Based Therapies

Kytopen - The Future in Cell Therapy Discovery and Manufacturing

Frédéric Desdouits on LinkedIn: Stem-cell start-ups seek to crack

BioCentriq, Kytopen expand partnership on cell therapy

Stem Cell Production: Processes, Practices, and Regulation

Kytopen - The Future in Cell Therapy Discovery and Manufacturing

Stem cell bioengineering: building from stem cell biology